Hanke Stefan, Besir Hüseyin, Oesterhelt Dieter, Mann Matthias
Department of Proteomics and Signal Transduction, Max Planck Institute for Biochemistry, Am Klopferspitz 18, 82152 Martinsried, Munich, Germany.
J Proteome Res. 2008 Mar;7(3):1118-30. doi: 10.1021/pr7007175. Epub 2008 Feb 14.
Mass spectrometry based proteomics can routinely identify hundreds of proteins in a single LC-MS run, and methods have been developed for relative quantitation between differentially treated samples using stable isotopes. However, absolute quantitation has so far required addition of a labeled standard late in the experimental workflow, introducing variability due to sample preparation. Here we present a new variant of the stable isotope labeling by amino acids in cell culture (SILAC) technique termed "Absolute SILAC" that allows accurate quantitation of selected proteins in complex mixtures. SILAC-labeled recombinant proteins produced in vivo or in vitro are used as internal standards, which are directly mixed into lysates of cells or tissues. This minimizes differences in sample processing between the isotope-labeled standard and its endogenous counterpart. We show that it is possible to quantify over several orders of magnitude, even in the background of a whole cell lysate. We furthermore devise a strategy to quantify peptides at or below their signal-to-noise level on hybrid ion trap instruments, shown here for the LTQ-Orbitrap. The data system triggers on peptides of the SILAC-labeled protein, initiating ion collection in a narrow mass range including the endogenous and labeled peptide. This strategy extends the regular detection limit of an LTQ-Orbitrap by at least an order of magnitude and accurately quantifies down to 150 attomole of protein in a cell lysate without any fractionation prior to LC-MS. We use Absolute SILAC to determine the copy number per cell of growth factor receptor-bound protein 2 (Grb2) in HeLa, HepG2, and C2C12 cells to 5.5 x 10(5), 8.8 x 10(5), and 5.7 x 10(5), respectively, in the exponential growth phase.
基于质谱的蛋白质组学技术通常能够在一次液相色谱-质谱联用(LC-MS)分析中鉴定出数百种蛋白质,并且已经开发出了利用稳定同位素对差异处理样本进行相对定量的方法。然而,迄今为止,绝对定量需要在实验工作流程后期添加标记标准品,这会因样品制备而引入变异性。在此,我们提出了一种细胞培养中氨基酸稳定同位素标记(SILAC)技术的新变体,称为“绝对SILAC”,它能够对复杂混合物中的选定蛋白质进行准确的定量。体内或体外产生的SILAC标记重组蛋白用作内标,直接混入细胞或组织裂解物中。这最大限度地减少了同位素标记标准品与其内源性对应物之间在样品处理上的差异。我们表明,即使在全细胞裂解物的背景下,也能够在几个数量级范围内进行定量。此外,我们设计了一种策略,用于在混合离子阱仪器上对信噪比水平及以下的肽段进行定量,此处以LTQ- Orbitrap为例进行展示。数据系统触发SILAC标记蛋白的肽段,在包括内源性肽段和标记肽段的狭窄质量范围内启动离子收集。该策略将LTQ- Orbitrap的常规检测限至少提高了一个数量级,并且在LC-MS之前无需任何分级分离就能准确地对细胞裂解物中低至150阿托摩尔的蛋白质进行定量。我们使用绝对SILAC来确定HeLa、HepG2和C2C12细胞在指数生长期时生长因子受体结合蛋白2(Grb2)的每个细胞拷贝数,分别为5.5×10⁵、8.8×10⁵和5.7×10⁵。